[ Price : $8.95]
HHS acting general counsel Sean Keveney is appointed FDAs new chief counsel.[ Price : $8.95]
FDA grants Dyne Therapeutics a breakthrough therapy designation for DYNE-251 for treating patients with Duchenne muscular dystroph...[ Price : $8.95]
FDA grants TransMedics Group conditional approval to begin its next-generation Organ Care System ENHANCE heart trial.[ Price : $8.95]
FDA approves Novo Nordisks Alhemo (concizumab-mtci) as a once-daily preventive treatment for bleeding episodes in patients 12 year...[ Price : $8.95]
FDA issues Regeneron a second complete response letter on its BLA for odronextamab and its use in relapsed/refractory follicular l...[ Price : $8.95]
Allogene Therapeutics modifies its ALPHA3 clinical trial for large B-cell lymphoma following the death of a patient attributed to ...[ Price : $8.95]
FDA approves LENZ Therapeutics Vizz (aceclidine ophthalmic solution) 1.44% for treating presbyopia, a common age-related condition...[ Price : $8.95]
Illumina agrees to pay $9.8 million to settle allegations that it violated the False Claims Act by selling genomic sequencing syst...